Back

Silencing the messenger: RNAi therapeutics as a new class of innovative medicines.

29 August 2021 (09:30 - 09:52)
Organised by:
Congress Presentation Part of: ESC Paul Hugenholtz Lecture for Innovation and William Harvey Lecture on Basic Science Genetics, Epigenetics, ncRNA ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor John Maraganore

Cambridge (United States of America)

2 More presentations in this session

Presentation thumbnail
HFpEF: malady, model, meta-inflammatory mechanisms.
Professor J. Hill (Dallas, US)
Slides Video
Presentation thumbnail
ESC Paul Hugenholtz Lecture for Innovation and William Harvey Lecture on Basic Science - Chat Moderator.

Access the full session

Session thumbnail
ESC Paul Hugenholtz Lecture for Innovation and William Harvey Lecture on Basic Science
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 09:30 CET
You may be interested in
thumbnail
Congress Session
New frontiers in heart failure therapies
19 May 2025
thumbnail
Congress Presentation
Inclisiran patient experiences survey
13 June 2025
thumbnail
Congress Presentation
RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency
31 August 2020
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources